Guardant Health Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Guardant Health Inc. (GH) Reports Q3 Loss of $1.94, Revenues Beat; Offers FY18 Revenue Guidance Above Consensus
November 19, 2018 4:12 PM ESTGuardant Health Inc. (NASDAQ: GH) reported Q3 EPS of ($1.94), versus ($2.76) reported last year. Revenue for the quarter came in at $21.7 million versus the consensus estimate of $17.5 million.
Revenues of $21.7 million for the third quarter of 2018, representing a 95% increase over the third quarter of 2017Reported 7,027 tests to clinical customers and 2,505 tests to biopharmaceutical customers in the third quarter,... More